Tumor type M2 pyruvate kinase expression in gastric cancer, colorectal cancer and controls

Table 2 Concentration of tumor M₂-PK and common clinical status in 54 patients with colorectal cancer

No.	Tumor M2-PKstage (U/mL)	Dukes stage	Metastasis	No.	Tumor M2-PKstage (U/mL)	Dukes stage	Metastasis
1	16.14	A	N	28	11.35	A	N
2	14.35	A	N	29	37.86	A	M
3	21.96	A	N	30	41.3	A	M
4	9.86	B	N	31	21.5	B	N
5	28.71	B	N	32	13.6	B	N
6	16.29	A	N	33	6.42	A	N
7	29.75	C1	M	34	10.76	C1	N
8	20.93	A	N	35	15.78	A	N
9	18.83	C1	M	36	12.4	C1	N
10	14.8	C1	M	37	56.4	C1	M
11	20.93	A	N	38	76.32	A	M
12	15.09	C1	M	39	14.85	C1	N
13	113.8	C1	M	40	8.76	C1	N
14	18.55	B	N	41	22.35	B	M
15	67.02	C1	M	42	28.13	C1	M
16	20.05	B	N	43	33.46	B	M
17	20.05	A	N	44	25.78	A	N
18	17.95	C1	M	45	7.93	C1	N
19	91.7	C1	M	46	13.44	C1	N
20	20.2	B	N	47	48.66	B	M
21	29.75	C1	M	48	106.3	C1	M
22	86.16	C1	M	49	14.78	C1	N
23	53.11	C1	M	50	10.66	C1	N
24	108.75	B	N	51	23.35	B	N
25	42.19	A	N	52	30.16	A	N
26	7.72	A	N	53	6.11	A	N
27	19.26	B	N	54	9.45	B	N

N = non metastasis, M = metastasis.